AMLX vs MSFT: Which Stock is Better?
Side-by-side comparison of Amylyx Pharmaceuticals Inc and Microsoft Corp in 2026
AMLX
Amylyx Pharmaceuticals Inc
$14.29
MSFT
Microsoft Corp
$395.22
Key Metrics Comparison
| Metric | AMLX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.59B | N/A | AMLX |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -1.0% | 14.9% | MSFT |
| Gross Margin | 13594.6% | 68.8% | AMLX |
Analyze AMLX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMLX or MSFT a better investment?
Comparing AMLX and MSFT: Amylyx Pharmaceuticals Inc has a market cap of $1.59B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMLX and MSFT?
AMLX (Amylyx Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMLX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AMLX or MSFT?
MSFT has higher revenue growth at 14.9% vs -1.0% for AMLX.
Which company is more profitable: AMLX or MSFT?
Amylyx Pharmaceuticals Inc (AMLX) has higher gross margins at 13594.6% compared to 68.8% for MSFT.
Which is the larger company: AMLX or MSFT?
Amylyx Pharmaceuticals Inc (AMLX) is larger with a market cap of $1.59B compared to N/A for MSFT.
Should I buy AMLX or MSFT in 2026?
Both AMLX and MSFT have investment merit. AMLX trades at $14.29 while MSFT trades at $395.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMLX and MSFT stock?
Key differences: Market Cap ($1.59B vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (-1.0% vs 14.9%), Gross Margin (13594.6% vs 68.8%).